JP2002531129A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531129A5 JP2002531129A5 JP2000586916A JP2000586916A JP2002531129A5 JP 2002531129 A5 JP2002531129 A5 JP 2002531129A5 JP 2000586916 A JP2000586916 A JP 2000586916A JP 2000586916 A JP2000586916 A JP 2000586916A JP 2002531129 A5 JP2002531129 A5 JP 2002531129A5
- Authority
- JP
- Japan
- Prior art keywords
- clone
- seq
- trachomatis
- nos
- identified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102100019488 CCDC130 Human genes 0.000 description 1
- 101710008444 CCDC130 Proteins 0.000 description 1
- 229940038705 Chlamydia trachomatis Drugs 0.000 description 1
- 229920001850 Nucleic acid sequence Polymers 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000692 anti-sense Effects 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Description
４つの陽性プールを同定した。これを破壊して、４つの純粋なクローン（１−Ｂ１−６６、４−Ｄ７−２８、３−Ｇ３−１０および１０−Ｃ１０−３１といわれる）を、それぞれ、４８１ｂｐ、１８３ｂｐ、１１０ｂｐおよび１４００ｂｐのインサートの大きさで得た。１−Ｂ１−６６、４−Ｄ７−２８、３−Ｇ３−１０および１０−Ｃ１０−３１について決定されたＤＮＡ配列を、それぞれ、配列番号１〜４に提供する。クローン１−Ｂ１−６６は、Ｃ．ｔｒａｃｈｏｍａｔｉｓゲノムのおよその領域５３６６９０（ＮＣＢＩ Ｃ．ｔｒａｃｈｏｍａｔｉｓデータベース）にある。クローン１−Ｂ１−６６内には、以前に同定された９ｋＤａタンパク質（Ｓｔｅｐｈｅｎｓら、Ｇｅｎｂａｎｋ登録番号ＡＥ００１３２０）をコードするオープンリーディングフレーム（ＯＲＦ）（ヌクレオチド１１５−３７５）が同定されており、この配列を、配列番号５に提供する。クローン４−Ｄ７−２８は、同じＯＲＦのより小さな領域である（１−Ｂ１−６６のアミノ酸２２〜８２）。クローン３−Ｇ３−１０は、Ｃ．ｔｒａｃｈｏｍａｔｉｓゲノムのおよその領域７４５５９にある。このインサートを、このゲノムのその配向に関してアンチセンスの配向においてクローニングする。クローン１０−Ｃ１０−３１は、Ｃｈｌａｍｙｄｉａ ｔｒａｃｈｏｍａｔｉｓ由来のＳ１３リボソームタンパク質について以前に公開された配列に対応するオープンリーディングフレームを含む（Ｇｕ，Ｌ．ら、Ｊ．Ｂａｃｔｅｒｉｏｌｏｇｙ、１７７：２５９４〜２６０１、１９９５）。４−Ｄ７−２８および１０−Ｃ１０−３１についての推定タンパク質配列を、それぞれ、配列番号６および１２に提供する。３−Ｇ３−１０についての推定タンパク質配列を、配列番号７〜１１に提供する。
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/208,277 | 1998-12-08 | ||
| US09/208,277 US6166177A (en) | 1998-12-08 | 1998-12-08 | Compounds and methods for the treatment and diagnosis of chlamydial infection |
| US09/288,594 US6447779B1 (en) | 1998-12-08 | 1999-04-08 | Compounds for the diagnosis of Chlamydial infection |
| US09/288,594 | 1999-04-08 | ||
| US09/410,568 US6555115B1 (en) | 1998-12-08 | 1999-10-01 | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US09/410,568 | 1999-10-01 | ||
| US42657199A | 1999-10-22 | 1999-10-22 | |
| US09/426,571 | 1999-10-22 | ||
| PCT/US1999/029012 WO2000034483A2 (en) | 1998-12-08 | 1999-12-08 | Compounds and methods for treatment and diagnosis of chlamydial infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010209037A Division JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531129A JP2002531129A (ja) | 2002-09-24 |
| JP2002531129A5 true JP2002531129A5 (ja) | 2010-06-03 |
Family
ID=27498718
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586916A Pending JP2002531129A (ja) | 1998-12-08 | 1999-12-08 | クラミジア感染の処置および診断のための化合物および方法 |
| JP2010209037A Withdrawn JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010209037A Withdrawn JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Country Status (18)
| Country | Link |
|---|---|
| EP (5) | EP1144642B1 (ja) |
| JP (2) | JP2002531129A (ja) |
| KR (4) | KR100829407B1 (ja) |
| CN (1) | CN100365120C (ja) |
| AT (1) | ATE469222T1 (ja) |
| AU (2) | AU769293B2 (ja) |
| BR (1) | BR9916020A (ja) |
| CA (2) | CA2354232A1 (ja) |
| DE (1) | DE69942426D1 (ja) |
| ES (1) | ES2346832T3 (ja) |
| HK (1) | HK1044020B (ja) |
| HU (1) | HUP0400719A3 (ja) |
| IL (5) | IL143531A0 (ja) |
| MX (1) | MXPA01005813A (ja) |
| NO (2) | NO20012812L (ja) |
| NZ (1) | NZ512246A (ja) |
| TR (1) | TR200102500T2 (ja) |
| WO (1) | WO2000034483A2 (ja) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459524B1 (en) | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
| CA2326002A1 (en) * | 1998-04-20 | 1999-10-28 | The State Of Oregon Acting By And Through The State Board Of Higher Educ Ation On Behalf Of Oregon State University | Chlamydia proteins and their uses |
| US6686339B1 (en) | 1998-08-20 | 2004-02-03 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| WO2000011180A1 (en) | 1998-08-20 | 2000-03-02 | Connaught Laboratories Limited | NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA) |
| CA2340330A1 (en) | 1998-08-20 | 2000-03-02 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein c of chlamydia |
| US6649370B1 (en) | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6607730B1 (en) | 1998-11-02 | 2003-08-19 | Aventis Pasteur Limited/Aventis Pasteur Limitee | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| JP2002531093A (ja) | 1998-12-01 | 2002-09-24 | アベンティス、パストゥール、リミテッド | クラミジア抗原および対応するｄｎａ断片ならびにその使用 |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1144642B1 (en) | 1998-12-08 | 2010-05-26 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6555115B1 (en) | 1998-12-08 | 2003-04-29 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6432916B1 (en) | 1998-12-08 | 2002-08-13 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6447779B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds for the diagnosis of Chlamydial infection |
| US6448234B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| US7297341B1 (en) | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| DE69938059T2 (de) | 1998-12-28 | 2009-01-08 | Sanofi Pasteur Ltd., Toronto | Chlamydia antigene, entsprechende dna-fragmente und ihre verwendungen |
| US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| EP1163342B1 (en) | 1999-03-12 | 2008-12-10 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| WO2000066739A2 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| NZ517952A (en) | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| NZ520200A (en) | 1999-12-22 | 2004-04-30 | Aventis Pasteur | Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product |
| US6919187B2 (en) | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1278855B1 (en) | 2000-04-21 | 2008-03-12 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1282718B1 (en) | 2000-05-08 | 2006-12-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US7731980B2 (en) | 2000-10-02 | 2010-06-08 | Emergent Product Development Gaithersburg Inc. | Chlamydia PMP proteins, gene sequences and uses thereof |
| US7537772B1 (en) * | 2000-10-02 | 2009-05-26 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, gene sequence and the uses thereof |
| GB2378056A (en) * | 2001-07-27 | 2003-01-29 | William Dixon | Electrical connection device |
| NZ562929A (en) | 2001-12-12 | 2009-07-31 | Novartis Vaccines & Diagnostic | Immunisation against chlamydia trachomatis |
| GB0203403D0 (en) | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
| JP2004261017A (ja) * | 2003-02-27 | 2004-09-24 | Arkray Inc | クラミジア・トラコマティスの検出方法およびそのためのキット |
| CN101184504A (zh) * | 2005-03-31 | 2008-05-21 | 葛兰素史密丝克莱恩生物有限公司 | 针对衣原体感染的疫苗 |
| EP1981905B1 (en) * | 2006-01-16 | 2016-08-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Chlamydia vaccine |
| EP2068916A1 (en) * | 2006-10-04 | 2009-06-17 | GlaxoSmithKline Biologicals S.A. | Vaccines against chlamydial infection |
| US20100310593A1 (en) * | 2007-06-14 | 2010-12-09 | Emergent Product Development Gaithersburg Inc. | Vaccines Against Chlamydia Infection |
| US8568732B2 (en) | 2009-03-06 | 2013-10-29 | Novartis Ag | Chlamydia antigens |
| EP2557156B1 (en) * | 2010-03-23 | 2015-02-11 | Wako Pure Chemical Industries, Ltd. | Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same |
| US11850279B2 (en) | 2016-07-13 | 2023-12-26 | Ohio State Innovation Foundation | Platforms and methods for optimizing host antigen presentation and host antitumor and antipathogen immunity |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US4489710A (en) | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
| US4429008B1 (en) | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| JPS59116229A (ja) | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
| US4673562A (en) | 1983-08-19 | 1987-06-16 | The Children's Medical Center Corporation | Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents |
| US4873088A (en) | 1983-09-06 | 1989-10-10 | Liposome Technology, Inc. | Liposome drug delivery method and composition |
| US4625014A (en) | 1984-07-10 | 1986-11-25 | Dana-Farber Cancer Institute, Inc. | Cell-delivery agent |
| US4542225A (en) | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
| US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4699784A (en) | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| US4735792A (en) | 1987-04-28 | 1988-04-05 | The United States Of America As Represented By The United States Department Of Energy | Radioiodinated maleimides and use as agents for radiolabeling antibodies |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| WO1991002805A2 (en) | 1989-08-18 | 1991-03-07 | Viagene, Inc. | Recombinant retroviruses delivering vector constructs to target cells |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| KR100278157B1 (ko) | 1992-06-25 | 2001-01-15 | 장 스테판느 | 보조약을 함유하는 백신 조성물 |
| US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
| US5840297A (en) * | 1993-03-19 | 1998-11-24 | Johns Hopkins University | Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| ES2321346T3 (es) * | 1994-09-20 | 2009-06-04 | Hitachi Chemical Co., Ltd. | Polinucleotidos que codifican un polipeptido antigenico de chlamydia pneumoniae. |
| JPH10509325A (ja) * | 1994-11-17 | 1998-09-14 | マキシム ファーマシューティカルズ，インコーポレイテッド | 粘膜免疫を刺激する免疫原 |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| EP0832282A1 (en) | 1995-06-02 | 1998-04-01 | Incyte Pharmaceuticals, Inc. | IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |
| EP0871747A1 (en) | 1996-01-02 | 1998-10-21 | Chiron Viagene, Inc. | Immunostimulation mediated by gene-modified dendritic cells |
| DE69734882T2 (de) * | 1996-07-12 | 2006-08-17 | University Of Manitoba, Winnipeg | Dna immunisierung gegen chlamydia infektion |
| US6464979B1 (en) * | 1996-09-12 | 2002-10-15 | Aventis Pasteur Limited | Chlamydial vaccines and methods of preparation thereof |
| CA2307846A1 (en) | 1997-11-21 | 1999-06-03 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| EP2218731A1 (en) * | 1997-11-28 | 2010-08-18 | Merck Serono Biodevelopment | Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| MXPA01001639A (es) * | 1998-08-20 | 2004-09-06 | Connaught Lab | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. |
| JP2002529069A (ja) | 1998-11-12 | 2002-09-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | クラミジア・ニューモニエのゲノム配列 |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1144642B1 (en) | 1998-12-08 | 2010-05-26 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| WO2000066739A2 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| NZ517952A (en) | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| EP1246935B1 (en) * | 1999-09-28 | 2013-08-14 | Geneohm Sciences Canada Inc. | Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| NZ520200A (en) | 1999-12-22 | 2004-04-30 | Aventis Pasteur | Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product |
| EP1278855B1 (en) | 2000-04-21 | 2008-03-12 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1282718B1 (en) | 2000-05-08 | 2006-12-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| ATE440861T1 (de) | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US9103184B2 (en) | 2013-03-08 | 2015-08-11 | Tejas Research & Engineering, Llc | Inflow control valve |
| PL3180356T3 (pl) | 2014-08-11 | 2020-04-30 | Daiichi Sankyo Europe Gmbh | Ludzkie przeciwciało anty-fgfr4 |
-
1999
- 1999-12-08 EP EP99963037A patent/EP1144642B1/en not_active Expired - Lifetime
- 1999-12-08 NZ NZ512246A patent/NZ512246A/en not_active IP Right Cessation
- 1999-12-08 TR TR2001/02500T patent/TR200102500T2/xx unknown
- 1999-12-08 KR KR1020017007165A patent/KR100829407B1/ko not_active IP Right Cessation
- 1999-12-08 DE DE69942426T patent/DE69942426D1/de not_active Expired - Lifetime
- 1999-12-08 JP JP2000586916A patent/JP2002531129A/ja active Pending
- 1999-12-08 KR KR1020077022107A patent/KR20070108263A/ko not_active Application Discontinuation
- 1999-12-08 CA CA002354232A patent/CA2354232A1/en not_active Abandoned
- 1999-12-08 EP EP10163839A patent/EP2223935A3/en not_active Withdrawn
- 1999-12-08 AT AT99963037T patent/ATE469222T1/de not_active IP Right Cessation
- 1999-12-08 KR KR1020107027275A patent/KR20100132086A/ko active IP Right Grant
- 1999-12-08 BR BR9916020-0A patent/BR9916020A/pt not_active Application Discontinuation
- 1999-12-08 HU HU0400719A patent/HUP0400719A3/hu unknown
- 1999-12-08 ES ES99963037T patent/ES2346832T3/es not_active Expired - Lifetime
- 1999-12-08 WO PCT/US1999/029012 patent/WO2000034483A2/en active IP Right Grant
- 1999-12-08 EP EP10179022A patent/EP2277892A3/en not_active Withdrawn
- 1999-12-08 CA CA2746535A patent/CA2746535A1/en not_active Abandoned
- 1999-12-08 EP EP10179569A patent/EP2277893A3/en not_active Withdrawn
- 1999-12-08 CN CNB998157236A patent/CN100365120C/zh not_active Expired - Fee Related
- 1999-12-08 KR KR1020097016159A patent/KR20090088972A/ko not_active Application Discontinuation
- 1999-12-08 AU AU19358/00A patent/AU769293B2/en not_active Ceased
- 1999-12-08 MX MXPA01005813A patent/MXPA01005813A/es active IP Right Grant
- 1999-12-08 IL IL14353199A patent/IL143531A0/xx unknown
- 1999-12-08 EP EP10163838A patent/EP2218733A1/en not_active Withdrawn
-
2001
- 2001-06-07 NO NO20012812A patent/NO20012812L/no not_active Application Discontinuation
-
2002
- 2002-07-26 HK HK02105516.2A patent/HK1044020B/zh not_active IP Right Cessation
-
2004
- 2004-04-22 AU AU2004201702A patent/AU2004201702B2/en not_active Ceased
-
2010
- 2010-09-14 NO NO20101293A patent/NO20101293L/no not_active Application Discontinuation
- 2010-09-17 JP JP2010209037A patent/JP2011036258A/ja not_active Withdrawn
- 2010-11-04 IL IL209114A patent/IL209114A0/en unknown
- 2010-11-04 IL IL209115A patent/IL209115A0/en unknown
- 2010-11-04 IL IL209116A patent/IL209116A0/en unknown
- 2010-11-04 IL IL209113A patent/IL209113A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531129A5 (ja) | ||
| Yamada et al. | Nucleotide sequence of the structural gene for colicin E1 and predicted structure of the protein. | |
| JP2008538183A5 (ja) | ||
| JP2002537791A5 (ja) | ||
| JP2007502101A5 (ja) | ||
| JP2003515323A5 (ja) | ||
| JP2006149395A5 (ja) | ||
| JP2004511201A5 (ja) | ||
| RU2007139915A (ru) | Haemophilus influenzae типа в | |
| CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
| JP2003501022A5 (ja) | ||
| JP2006501825A5 (ja) | ||
| RU2006105498A (ru) | Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus | |
| JP2004524824A5 (ja) | ||
| JP2003525623A5 (ja) | ||
| CA2395499A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JP2003510050A5 (ja) | ||
| PH12021550030A1 (en) | Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof | |
| JP2001512666A5 (ja) | ||
| JP2002517193A5 (ja) | ||
| JP2005509420A5 (ja) | ||
| HU216619B (hu) | Rekombináns mersacidin és eljárás előállítására | |
| JP2009507474A5 (ja) | ||
| JP2004502446A5 (ja) | ||
| CA2202519A1 (en) | Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase |